Patients diagnosed with systemic sarcoidosis have nearly 20 percent incidence of ocular involvement. The most prevalent ocular sign is unilateral, anterior, granulomatous uveitis.
Studies underscore that lymphocytes interact with macrophages.
Q1H to QID if necessary, oral steroidal or nonsteroidal anti-inflammatories. Antimetabolites such as methotrexate and cyclosporin-A have been used effectively in patients intolerant to steroids. Add topical aqueous suppressants if intraocular pressure control is required. Allow the retinologist to manage peripheral retinal neovascularization and pars planitis with panretinal photocoagulation and oral or injected steroids respectively. The primary care physician can lead systemic management.